SERPINE1 and pulmonary fibrosis: To conclude, publications over several decades have emphasized PAI-1 as an attractive therapeutic target for the treatment of lung fibrosis, including several reports employing PAI-1 inhibitors to attenuate the severity of scarring in different animal models.